Antihypertensive treatment and sexual dysfunction

Current Hypertension Reports

Volumn 14, Issue 4, 2012, Pages 285-292

  Manolis, Athanasios ^a   Doumas, Michael ^b  

^a IASO GENERAL HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

ACE inhibitors; Alpha blockers; Angiotensin receptor blockers; Antihypertensive drugs; Antihypertensive therapy; Beta blockers; Diuretics; Erectile dysfunction; Female sexual dysfunction; Hypertension; Lifestyle modification; PDE 5 inhibitors; Sexual dysfunction

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FELODIPINE; IRBESARTAN; METOPROLOL; NEBIVOLOL; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; RAMIPRIL; SILDENAFIL; TADALAFIL; TELMISARTAN; VARDENAFIL;

ARTICLE; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; FEMALE SEXUAL DYSFUNCTION; FOOD; FOOD DRUG INTERACTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LOW DRUG DOSE; NONHUMAN; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; WEIGHT REDUCTION;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; IMPOTENCE, VASCULOGENIC; MALE; PHOSPHODIESTERASE 5 INHIBITORS; RISK FACTORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 84865630794     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-012-0276-5     Document Type: Article

References (64)

1. Manolis A, Doumas M. Sexual dysfunction: The 'prima ballerina' of hypertension-related quality-of-life complications. J Hypertens. 2008;26:2074-84. A comprehensive review revealing the association of arterial hypertension and sexual dysfunction, and its impact on life quality.
2. Doumas M, Douma S. Sexual dysfunction in essential hypertension: Myth or reality? J Clin Hypertens. 2006;8:269-74.
3. Doumas M, Douma S. The effect of antihypertensive drugs on erectile function: A proposedmanagement algorithm. J Clin Hypertens. 2006;8:359-64.
4. Manolis A, Doumas M. Hypertension and sexual dysfunction. Arch Med Sci. 2009;5:S337-50.
5. Douma S, Doumas M, Tsakiris A, Zamboulis C. Male and female sexual dysfunction: Is hypertension an innocent bystander or a major contributor? Rev Bras Hypertens. 2007;14:139-47.
6. Doumas M, Tsakiris A, Douma S, et al. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects. J Androl. 2006;27:469-77. (Pubitemid 43667997)
7. Doumas M, Tsiodras S, Tsakiris A, et al. Female sexual dysfunction in essential hypertension: A common problem being uncovered. J Hypertens. 2006;24:2387-92. (Pubitemid 44684686)
8. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005;365:217-23. (Pubitemid 40138015)
9. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible consequences. Br J Urol Int. 1999;84:50-6. (Pubitemid 29346774)
10. Manolis AJ, Doumas M, Viigimaa M, Narkiewitz K. Hypertension and sexual dysfunction. European Society of Hypertension Scientific Newsletter: Update on Hypertension Management 2007;8.
11. Manolis AJ, Doumas M, Viigimaa M, Narkiewitz K. Hypertension and sexual dysfunction. European Society of Hypertension Scientific Newsletter: Update on Hypertension Management 2011;32.
12. Viigimaa M, Doumas M, Vlachopoulos C, et al. European Society of Hypertension Working Group on Sexual Dysfunction. Hypertension and sexual dysfunction: Time to act. J Hypertens. 2011;29:403-7. doi:403. A position paper from the European Society of Hypertension, highlighting the causes of sexual dysfunction in patients with arterial hypertension, and the significance of this entity.
13. Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: A randomized controlled trial. JAMA. 2004;291:2978-84. The first randomized study to evaluate the effects of lifestyle modification on erectile function. A significant improvement of erectile function was observed with weight reduction. (Pubitemid 38802687)
14. Wing RR, Rosen RC, Fava JL, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the look AHEAD trial. J Sex Med. 2010;7:156-65.
15. Dallal RM, Chernoff A, O'Leary MP, et al. Sexual dysfunction is common in the morbidly obese male and improves after gastric bypass surgery. J Am Coll Surg. 2008;207:859-64.
16. Esposito K, Ciotola M, Giugliano F, et al. Mediterranean diet improves sexual function in women with the metabolic syndrome. Int J Impot Res. 2007;19:486-91. (Pubitemid 47367522)
17. Esposito K, Ciotola M, Giugliano F, et al. Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res. 2006;18:405-10.
18. Hannan JL, Maio MT, Komolova M, Adams MA. Beneficial impact of exercise and obesity interventions on erectile function and its risk factors. J Sex Med. 2009;6:S254-61.
19. Lamina S, Okoye CG, Dagogo TT. Therapeutic effect of an interval exercise training program in the management of erectile dysfunction in hypertensive patients. J Clin Hypertens. 2009; 11:125-9.
20. Claudino M, Delbin M, Franco-Penteado C, et al. Exercise training ameliorates the impairment of endothelial and nitrergic corpus cavernosum responses in diabetic rats. Life Sci. 2011;88:272-7.
21. Doumas M, Anyfanti P, Triantafyllou A. Management of erectile dysfunction: Do not forget hypertension. Arch Intern Med. 2012;172:597-8.
22. Gupta B, Murad H, Clifton M, et al. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction. Arch Intern Med. 2011;171:1797-803. An important meta-Analysis of studies assessing the effect of lifestyle modification on erectile function.
23. Helmy M, Senbel A. Evaluation of vitamin E in the treatment of erectile dysfunction in aged rats. Life Sci. 2012;90:489-94.
24. Cormio L, SiatiM, Lorusso F, et al. Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. Urology. 2011;77:119-22.
25. Ernst E, Posadzki P, Lee M. Complementary and alternative medicine (CAM) for sexual dysfunction and erectile dysfunction in older men and women: An overview of systematic reviews. Maturitas. 2011;70:37-41.
26. Toblli J, Stella I, Néstor Mazza O, Ferder L, Inserra F. Protection of cavernous tissue in male spontaneously hypertensive rats. Beyond blood pressure control. Am J Hypertens. 2004;17:516-22. (Pubitemid 38726167)
27. Toblli JE, Cao G, Casas G,Mazza ON. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats. Am J Hypertens. 2006;19:1226-32. (Pubitemid 44856250)
28. Cordero A, Bertomeu-Martinez V, Mazon P, et al. Erectile dysfunction in high-risk hypertensive patients treated with beta-blockers agents. Cardiovasc Ther. 2010;28:15-22.
29. Fogari R, Zoppi A, Poletti L, et al. Sexual activity in hypertensive men treated with valsartan or carvedilol: A crossover study. Am J Hypertens. 2001;14:27-31. (Pubitemid 32105914)
30. Fogari R, Preti P, Derosa G, et al. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol. 2001; 58:177-80.
31. Fogari R, Zoppi A, Corradi L, et al. Sexual function in hypertensive males treated with lisinopril or atenolol: A cross-over study. Am J Hypertens. 1998;11:1244-7.
32. Williams GH, Croog SH, Levine S, et al. Impact of antihypertensive therapy on quality of life: Effect of hydrochlorothiazide. J Hypertens. 1987;5:S29-35. (Pubitemid 17055002)
33. Ko DT, Hebert PR, Coffey CS, et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351-7. (Pubitemid 34761614)
34. Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): Aenefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol. 2007;34:327-31. A randomized study which unveils the beneficial effects of nebivolol on sexual function compared to older beta blockers.
35. Grimm RH, Grandits GA, Prineas RJ, Mc Donald RH, Lewis CE, Flack JM, et al. Long-Term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: Treatment of Mild Hypertension Study (TOMHS). Hypertension. 1997;29:8-14. (Pubitemid 27078334)
36. Medical Research Council Working Party on mild to moderate hypertension, report of 1981. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet. 1981;2:539-543.
37. Wassertheil-Smoller S, Blaufox MD, Oberman A, et al. Effect of antihypertensives on sexual function and quality of life: The TAIM study. Ann Intern Med. 1991;114:613-20.
38. Lindholm LH, Persson M, Alaupovic P, et al. Metabolic outcome during 1 year in newly detected hypertensives: results of the antihypertensive treatment and lipid profile in a north of Sweden efficacy evaluation (ALPINE study). J Hypertens. 2003;21:1563-74. (Pubitemid 36994137)
39. Bechara AJ, Cao G, Casabé AR, Romano SV, Toblli JE. Morphological modifications in clitoris and vagina in spontaneously hypertensive rats. Int J Impot Res. 2003;15:166-72. (Pubitemid 36928908)
40. Fogari R, Preti P, Zoppi A, et al. Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. Am J Hypertens. 2004;17:77-81. (Pubitemid 38064765)
41. Ma R, Yu J, Xu D, et al. Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension. J Hypertens. 2011;30:210-6. An important randomized study of combination therapy in hypertensive women, which shows that ARBs exert beneficial effects on female sexual function compared to beta blockers when either drug is combined with calcium antagonists.
42. Doumas M, Anyfanti P, Lazaridis N. Effects of antihypertensive therapy on female sexual dysfunction: Clinically meaningful? J Hypertens 2012; In press.
43. Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005;96:313-21. (Pubitemid 40978596)
44. Dusing R. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press. 2003;12:S29-34.
45. Della Chiesa A, Pfifner D, Meier B, et al. Sexual activity in hypertensive men. J Hum Hypertens. 2003;17:515-21. (Pubitemid 36949446)
46. Llisterri JL, Lozano Vidal JV, Aznar Vicente J, et al. Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci. 2001;321:336-41. (Pubitemid 32428834)
47. Doumas M, Tsakiris A, Douma S, et al. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients. Asian J Androl. 2006;8:177-82. (Pubitemid 43349188)
48. Baumhakel M, Schlimmer N, Bohm M. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome. Int J Impot Res. 2008;20:493-500.
49. Douma S, Doumas M, Petidis K, Triantafyllou A, Zamboulis C. Beta blockers and sexual dysfunction: Aad guys -good guys. In: Beta Blockers: New Research -editors: Momoka Endo and Narami Matsumoto. Nova Science Publishers Inc. 2008;1-13.
50. Baumhakel M, Schimmer N, Kratz M, et al. Cardiovascular risk, drugs and erectile function -A systematic analysis. Int J Clin Pract. 2011;65:289-98.
51. Silvestri A, Galetta P, Cerquetani E, et al. Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J. 2003;24:1928-32. (Pubitemid 37322702)
52. Cocco G. Erectile dysfunction after therapy with metoprolol: The Hawthorne effect. Cardiology. 2009;112:174-7. 53. 9.
53. Böhm M, Baumhäkel M, Teo K, et al. ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators. Erectile Dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANCEND) Trials. Circulation. 2010;121:1439-46. The first substudy of a large, randomized trial evaluating the effect of ARBs on erectile function. It was found that erectile dysfunction is a strong predictor of cardiovascular events and that ARBs do not have any significant effect on erectile function. It has to be taken into account that ARBs were used on top of previous multidrug antihypertensive treatment.
54. Ballard SA, Gingell CJ, Tang K, et al. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol. 1998;159:2164-71. (Pubitemid 29190800)
55. Boolell M, Allen MJ, Ballard SA, et al. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res. 1996;8:47-52.
56. Maggi M, Filippi S, Ledda F, et al. Erectile dysfunction: From biochemical pharmacology to advances in medical therapy. Eur J Endocrinol. 2000;143:143-54. (Pubitemid 30622347)
57. Jackson G, Benjamin N, Jackson N, et al. Effects of sildenafil citrate on human hemodynamics. Am J Cardiol. 1999;83:13C-20C. (Pubitemid 29122753)
58. Emmick JT, Stuewe SR,MitchellM. Overview of the cardiovascular effects of tadalafil. Eur Heart J. 2002;4:H32-47. (Pubitemid 35396802)
59. Zusman RM, Prisant LM, Brown MJ. Effect of sildenafil citrate on blood pressure and heart rate in men with erectile dysfunction taking concomitant antihypertensive medication. Sildenafil Study Group. J Hypertens. 2000;18(12):1865-9.
60. Kloner RA, Mitchell M, Emmick JT. Cardiovascular effects of tadalafil. Am J Cardiol. 2003;92:37M-46M. (Pubitemid 37386274)
61. van Ahlen H, Wahle K, Kupper W, et al. Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives. J Sex Med. 2005; 2:856-64. (Pubitemid 41727399)
62. Pickering TG, Shepherd AM, Puddey I, et al. Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: A randomized controlled trial. Am J Hypertens. 2004; 17:1135-42. (Pubitemid 40029411)
63. McLaughlin T, Harnett J, Burhani S, Scott B. Evaluation of erectile dysfunction therapy in patients previously nonadherent to long-Term medications: A retrospective analysis of prescription claims. Am J Ther. 2005;12:605-11. (Pubitemid 41689762)
64. Scranton RE, Lawler E, Botteman M, et al. Effect of treating erectile dysfunction on management of systolic hypertension. Am J Cardiol. 2007;100:459-63. (Pubitemid 47094695)